Physician profile
Jordan Mccoy
NPI 1023498458
$13,168.75
in general payments reported to CMS, 2019-2025
13 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,225 · 2020: $423 · 2021: $452 · 2022: $1,424 · 2023: $4,839 · 2024: $2,044 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,077 · Food and Beverage: $3,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,077.12 |
| Food and Beverage | $3,568.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,401.15 | 2019-2025 | Mako, Insignia, Triathlon |
| Microport Orthopedics INC | $3,502.72 | 2023 | Mpo Hip System, Mpo Medial Pivot Knee |
| Medical Device Business Services, INC. | $2,891.05 | 2019-2025 | Tfn-Advance |
| Trimed, INC. | $514.98 | 2019-2020 | |
| Orthalign INC | $451.54 | 2022-2025 | Orthalign Plus |
| Medtronic, INC. | $159.34 | 2025 | Plasmablade(Tm), Aquamantys(Tm) |
| Zimmer Biomet Holdings, INC. | $81.09 | 2019-2025 | G7 |
| Depuy Synthes Sales INC. | $55.31 | 2023 | Attune |
| Bioventus LLC | $36.56 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Acumed LLC | $28.84 | 2019 | |
| Smith+Nephew, INC. | $17.08 | 2022 | |
| Restor3d, INC. | $15.23 | 2025 | |
| Organogenesis INC. | $13.86 | 2024 | Cygnus Dual |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.